Belimumab: the first US FDA approved biological therapy for systemic lupus erythematosus. (August 2011)

Record Type:: Journal Article
Title:: Belimumab: the first US FDA approved biological therapy for systemic lupus erythematosus. (August 2011)
Main Title:: Belimumab: the first US FDA approved biological therapy for systemic lupus erythematosus
Authors:: Mok, Chi Chiu
Abstract:
Is Part Of:: International journal of clinical rheumatology. Volume 6:Number 4(2011)
Journal:: International journal of clinical rheumatology
Issue:: Volume 6:Number 4(2011)
Issue Display:: Volume 6, Issue 4 (2011)
Year:: 2011
Volume:: 6
Issue:: 4
Issue Sort Value:: 2011-0006-0004-0000
Page Start:: 373
Page End:: 377
Publication Date:: 2011-08
Subjects:: BAFF -- B-cell depletion -- biologics -- immunomodulation -- lupus -- novel -- targeted therapy -- therapeutics -- therapy
Rheumatology -- Periodicals
616.723005
Journal URLs:: https://www.openaccessjournals.com/journals/clinical-rheumatology-archive.html ↗
http://www.futuremedicine.com/loi/ijr ↗
DOI:: 10.2217/ijr.11.33 ↗
Languages:: English
ISSNs:: 1758-4272
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 4542.172168
British Library HMNTS - Digital store
British Library HMNTS - ELD Digital store
Ingest File:: 16496.xml